Total Payments
$559,161
2024 Payments
$96,085
Companies
51
Transactions
1,155
Medicare Patients
7,593
Medicare Billing
$526,763
Payment Breakdown by Category
Other$264,777 (47.4%)
Consulting$217,723 (38.9%)
Travel$36,682 (6.6%)
Food & Beverage$32,341 (5.8%)
Research$7,418 (1.3%)
Education$204.93 (0.0%)
Gifts$14.99 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $217,723 | 222 | 38.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $154,702 | 82 | 27.7% |
| Compensation for serving as faculty or as a speaker for a medical education program | $56,213 | 24 | 10.1% |
| Honoraria | $42,813 | 31 | 7.7% |
| Travel and Lodging | $36,682 | 146 | 6.6% |
| Food and Beverage | $32,341 | 638 | 5.8% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $11,050 | 6 | 2.0% |
| Unspecified | $7,418 | 2 | 1.3% |
| Education | $204.93 | 3 | 0.0% |
| Gift | $14.99 | 1 | 0.0% |
Payments by Type
General
$551,743
1,153 transactions
Research
$7,418
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Shire North American Group Inc | $60,868 | 149 | $0 (2019) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $58,950 | 124 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $58,851 | 80 | $0 (2024) |
| Alcon Vision LLC | $51,169 | 104 | $0 (2024) |
| Oyster Point Pharma, Inc. | $37,331 | 51 | $0 (2024) |
| Allergan, Inc. | $34,676 | 113 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $31,564 | 43 | $0 (2023) |
| Sight Sciences, Inc. | $26,168 | 45 | $0 (2024) |
| ABBVIE INC. | $23,779 | 50 | $0 (2024) |
| Kala Pharmaceuticals, Inc. | $20,592 | 33 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $96,085 | 199 | Bausch & Lomb Americas Inc. ($35,822) |
| 2023 | $75,809 | 144 | Bausch & Lomb Americas Inc. ($20,078) |
| 2022 | $90,475 | 177 | ABBVIE INC. ($20,573) |
| 2021 | $54,040 | 125 | Kala Pharmaceuticals, Inc. ($15,462) |
| 2020 | $51,063 | 82 | Alcon Vision LLC ($10,580) |
| 2019 | $75,284 | 139 | Sun Pharmaceutical Industries Inc. ($19,900) |
| 2018 | $62,492 | 157 | Shire North American Group Inc ($23,210) |
| 2017 | $53,914 | 132 | Shire North American Group Inc ($23,578) |
All Payment Transactions
1,155 individual payment records from CMS Open Payments — Page 1 of 47
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: EYE CARE | ||||||
| 12/13/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), VYZULTA | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Ophthalmology | ||||||
| 12/13/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Ophthalmology | ||||||
| 12/12/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $31.90 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,700.00 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 12/11/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Travel and Lodging | In-kind items and services | $341.96 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 12/11/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Travel and Lodging | In-kind items and services | $97.37 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 12/11/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $94.50 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 12/11/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Travel and Lodging | In-kind items and services | $25.00 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 12/11/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $15.63 | General |
| 12/10/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Ophthalmology | ||||||
| 12/09/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Ophthalmology | ||||||
| 12/04/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,200.00 | General |
| Category: Ophthalmology | ||||||
| 12/04/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: Ophthalmology | ||||||
| 12/02/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Consulting Fee | Cash or cash equivalent | $375.00 | General |
| Category: Dry eyes | ||||||
| 12/01/2024 | Apellis Pharmaceuticals, Inc. | — | Honoraria | Cash or cash equivalent | $393.00 | General |
| 11/26/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $4,800.00 | General |
| Category: Ophthalmology | ||||||
| 11/26/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $2,400.00 | General |
| Category: Ophthalmology | ||||||
| 11/26/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $2,400.00 | General |
| Category: Ophthalmology | ||||||
| 11/25/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO, INFUSE | Compensation for serving as faculty or as a speaker for a medical education program | In-kind items and services | $3,000.00 | General |
| Category: Ophthalmology | ||||||
| 11/25/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO, INFUSE | Food and Beverage | In-kind items and services | $269.31 | General |
| Category: Ophthalmology | ||||||
| 11/25/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $27.98 | General |
| Category: Ophthalmology | ||||||
| 11/22/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $103.26 | General |
| Category: Ophthalmology | ||||||
| 11/22/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $44.03 | General |
| Category: Ophthalmology | ||||||
| 11/21/2024 | Alcon Vision LLC | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PUBLICATION SUPPORT PROVIDED IN CONNECTION WITH XIIDRA RESEARCH | Novartis Pharmaceuticals Corporation | $4,375 | 1 |
| Pooled by Severity | Oyster Point Pharma, Inc. | $3,043 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 2,013 | 2,678 | $867,447 | $169,473 |
| 2022 | 13 | 1,588 | 2,181 | $390,717 | $119,136 |
| 2021 | 15 | 1,410 | 1,630 | $493,314 | $81,137 |
| 2020 | 17 | 2,582 | 3,040 | $380,957 | $157,017 |
Total Patients
7,593
Total Services
9,529
Medicare Billing
$526,763
Procedure Codes
60
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 574 | 842 | $369,638 | $75,343 | 20.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 445 | 583 | $176,649 | $36,460 | 20.6% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 121 | 121 | $61,710 | $11,325 | 18.4% |
| 68761 | Closure of tear duct opening using plug | Office | 2023 | 46 | 71 | $69,230 | $10,080 | 14.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 88 | 88 | $58,344 | $9,294 | 15.9% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 191 | 207 | $52,992 | $9,096 | 17.2% |
| 83861 | Microfluid analysis of tears | Office | 2023 | 126 | 283 | $10,188 | $6,234 | 61.2% |
| 92133 | Imaging of optic nerve | Office | 2023 | 220 | 234 | $35,334 | $5,785 | 16.4% |
| 92134 | Imaging of retina | Office | 2023 | 91 | 93 | $17,205 | $2,799 | 16.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $6,944 | $1,120 | 16.1% |
| 83516 | Analysis of substance using immunoassay technique, multiple step method | Office | 2023 | 30 | 60 | $1,500 | $678.00 | 45.2% |
| 92071 | Fitting of contact lens for treatment of eye surface disease | Office | 2023 | 11 | 13 | $2,142 | $393.53 | 18.4% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 16 | 16 | $1,792 | $309.82 | 17.3% |
| 67820 | Removal of eyelashes using forceps | Office | 2023 | 16 | 19 | $2,211 | $283.94 | 12.8% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 22 | 32 | $1,568 | $273.22 | 17.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 379 | 450 | $134,190 | $45,141 | 33.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 351 | 393 | $87,054 | $27,397 | 31.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 90 | 90 | $36,760 | $10,966 | 29.8% |
| 83861 | Microfluid analysis of tears | Office | 2022 | 169 | 383 | $9,872 | $8,415 | 85.2% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 79 | 80 | $39,140 | $7,530 | 19.2% |
| 83516 | Analysis of substance using immunoassay technique, multiple step method | Office | 2022 | 179 | 430 | $10,750 | $4,838 | 45.0% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 76 | 81 | $17,590 | $3,967 | 22.6% |
| 92133 | Imaging of optic nerve | Office | 2022 | 125 | 125 | $19,918 | $3,584 | 18.0% |
| 68761 | Closure of tear duct opening using plug | Office | 2022 | 16 | 23 | $14,074 | $2,905 | 20.6% |
| 92134 | Imaging of retina | Office | 2022 | 68 | 69 | $13,170 | $2,182 | 16.6% |
About Dr. Walter Whitley, MD
Dr. Walter Whitley, MD is a Optometrist healthcare provider based in Norfolk, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013976711.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Walter Whitley, MD has received a total of $559,161 in payments from pharmaceutical and medical device companies, with $96,085 received in 2024. These payments were reported across 1,155 transactions from 51 companies. The most common payment nature is "Consulting Fee" ($217,723).
As a Medicare-enrolled provider, Whitley has provided services to 7,593 Medicare beneficiaries, totaling 9,529 services with total Medicare billing of $526,763. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Ad
Practice Information
- Specialty Optometrist
- Location Norfolk, VA
- Active Since 03/21/2006
- Last Updated 03/05/2013
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1013976711
Products in Payments
- XIIDRA (Drug) $92,619
- VUITY (Drug) $40,453
- MIEBO (Drug) $38,884
- TYRVAYA (Drug) $34,288
- Cequa (Drug) $28,008
- CEQUA (Drug) $26,885
- VYZULTA (Drug) $24,569
- EYSUVIS (Drug) $22,868
- XDEMVY (Drug) $18,330
- OXERVATE (Drug) $16,339
- ILUX (Device) $15,224
- Systane (Drug) $14,097
- DAILIES (Device) $10,105
- VEVYE (Drug) $9,647
- TearCare (Device) $9,641
- AcrySof (Device) $8,512
- Tecnis 1-piece IOL (Device) $7,951
- RESTASIS (Drug) $5,267
- OMNI (Device) $4,928
- TearCare SmartLid (Device) $4,810
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Norfolk
Dr. Jeffrey Klein, O.d, O.D
Optometrist — Payments: $19,014
Optometrist $19,014
Katherine Rachon, O.d, O.D
Optometrist — Payments: $10,188
Optometrist $10,188
Dr. Ann Feidler-Klein, O.d, O.D
Optometrist — Payments: $6,778
Optometrist $6,778
Dr. Ranjani Panda, Od, OD
Optometrist — Payments: $5,709
Optometrist $5,709
Patrizia Colmenares, Od, OD
Optometrist — Payments: $3,377
Optometrist $3,377
Dr. Steven Miller, O.d, O.D
Optometrist — Payments: $3,267
Optometrist $3,267